This trial has been completed.

Condition substance use
Treatments motivational interviewing w/social network counseling, active control condition
Sponsor Virginia Commonwealth University
Start date August 2012
End date November 2014
Trial size 120 participants
Trial identifier NCT01922947, 1R34DA032808-01A1


The purpose of this research is to test the feasibility and efficacy of a brief (one session) preventative intervention using motivational interviewing integrated with social network counseling for substance use among adolescent patients in a primary care setting. One hundred participants will be randomly assigned to either motivational interviewing integrated with social network counseling or attention control conditions. The motivational interviewing integrated with social network counseling condition is expected to show improvement when compared to the attention control condition.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Primary purpose treatment
Masking participant
(Active Comparator)
Motivational Interviewing integrated with Social Network Counseling, 20-minute session.
active control condition
20-minute health counseling
(Sham Comparator)
motivational interviewing w/social network counseling
This is the active arm of the study.

Primary Outcomes

Effects of counseling on substance use factors in teens
time frame: Feb. 2015

Eligibility Criteria

All participants from 14 years up to 18 years old.

Inclusion Criteria: - 14-18 years old - Resident of Richmond VA or greater Richmond area - Patient at Virginia Commonwealth University or Richmond City Department of Health Exclusion Criteria: - Ward of the state - Not fluent in English - Incapable of providing consent

Additional Information

Official title Motivational Interviewing Integrated With Social Network Counseling for Teens
Principal investigator Michael P Mason, PhD
Trial information was received from ClinicalTrials.gov and was last updated in February 2017.
Information provided to ClinicalTrials.gov by Virginia Commonwealth University.